Industry Comparables

OTC: CLCS

Stock Information

SHARE PRICE: $0.3097

VOLUME: 500

MARKET CAP: $13,462,102.00

SHARE COUNT: 43,468,200

DAILY HIGH: $0.3097

DAILY LOW: $0.3097

OPEN: $0.3097

CLOSE: $0.25

PREV. CLOSE: $0.25

CHANGE: $0.0597 (23.880005%)

52-WEEK HIGH: $0.8401

52-WEEK LOW: $0.0008

LAST UPDATED: 9 hours ago

CompanySymbolMarketcapPriceExchangeChart (24H)
Cell Source, Inc.CLCS13.46M$0.3097OQB
CompanySymbolMarketcapPriceExchangeChart (24H)
Allogene Therapeutics, Inc.ALLO253.70M$1.16NMS
Atara Biotherapeutics, Inc.ATRA43.34M$7.27NMS
bluebird bio, Inc.BLUE34.27M$3.50NMS
Fate Therapeutics, Inc.FATE119.19M$1.04NGM
KDMN0.0000$0.0000
Legend Biotech CorporationLEGN5.84B$31.78NMS

Investor Presentation

Investor Relations Contact

Cell Source, Inc.
57 West 57th Street, Suite 400
New York, NY 10019

Phone: 646-612-7554
Toll Free: 888-315-4650
Email: info@cell-source.com

Securities Counsel

Giordano Halleran & Ciesla
Philip D. Forlenza, Esq.
125 Half Mile Road, Suite 300
Red Bank, NJ 07701-6777

Phone: 732-741-3900
Email: PForlenza@ghclaw.com
WWW: www.ghclaw.com

Independent Auditor

Marcum LLP
750 Third Ave, 11th Floor
New York, NY 10017

Additional Information

Subscribe to Cell Source’s Newsletter

    INVESTOR ALERTS. PRESS RELEASES. INDUSTRY & COMPANY NEWS.

    Get the latest Cell Source news and updates, delivered right to your inbox.